sundan a
Norges teknisk-naturvitenskaplige universitet
H-index: 60
Europe-Norway
Top articles of sundan a
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Targeting FKBP12 enables bone morphogenetic proteins to kill multiple myeloma cells via ALK2 | Ingrid Quist-Løkken Clara Andersson-Rusch Martin Haugrud Kastnes Jürgen Markus Kolos Jerome Jatzlau | 2023/8/18 | |
FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells | Cell Communication and Signaling | Ingrid Quist-Løkken Clara Andersson-Rusch Martin Haugrud Kastnes Jürgen Markus Kolos Jerome Jatzlau | 2023/1/30 |
Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence | Leukemia | Kristine Misund Davine Hofste Op Bruinink Eivind Coward Remco M Hoogenboezem Even Holth Rustad | 2022/7 |
P950: COMBINED PROTEASOME AND AUTOPHAGY INHIBITION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA–A PHASE I TRIAL OF HYDROXYCHLOROQUINE, CARFILZOMIB AND DEXAMETHASONE | HemaSphere | Tobias S Slørdahl Frida Bugge Askeland Margrete Sofie Sætre Hanssen Stine Marie Sundt-Hansen Nils Tore Vethe | 2022/6/1 |
Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells | Iscience | Kristin Roseth Aass Robin Mjelle Martin H Kastnes Synne S Tryggestad Luca M van den Brink | 2022/1/21 |
IL-32 is a metabolic regulator promoting survival and proliferation of malignant plasma cells | bioRxiv | Kristin Roseth Aass Robin Mjelle Martin H Kastnes Synne S Tryggestad Luca M van den Brink | 2021/2/22 |
Bystander memory T cells and IMiD/checkpoint therapy in multiple myeloma: a dangerous tango? | Anne Marit Sponaas Anders Waage Esten N Vandsemb Kristine Misund Magne Børset | 2021/2/15 | |
Receptor binding competition: A paradigm for regulating TGF-β family action | Erik Martinez-Hackert Anders Sundan Toril Holien | 2021/2/1 | |
Why do myeloma patients have bone disease? A historical perspective | Magne Børset Anders Sundan Anders Waage Therese Standal | 2020/5/1 | |
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade | Journal for immunotherapy of cancer | Rui Yang Samah Elsaadi Kristine Misund Pegah Abdollahi Esten Nymoen Vandsemb | 2020 |
Bone morphogenetic protein 4 gene therapy in mice inhibits myeloma tumor growth, but has a negative impact on bone | Journal of Bone and Mineral Research Plus | Marita Westhrin Toril Holien Muhammad Zahoor Siv Helen Moen Glenn Buene | 2020/1/1 |
DEVELOPMENT OF MULTIPLE MYELOMA CELL LINES WITH HIGH EXPRESSION OF HEPATOCYTE GROWTH FACTOR | Journal of Khyber College of Dentistry | Fouzia Qadir Anders Sundan Maria Mufti Asad Jan | 2020/12/31 |
Monoclonal immunoglobulins promote bone loss in multiple myeloma | Blood, The Journal of the American Society of Hematology | Marita Westhrin Vlado Kovcic Zejian Zhang Siv H Moen Tonje Marie Vikene Nedal | 2020/12/3 |
Co-Authors
